ArticleTranslational oncology2025

Targeting FEN1/EXO1 to enhance efficacy of PARP inhibition in triple-negative breast cancer.

Mallory I Frederick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.